Different Levels of Oxygen Therapy Used for Pneumonia in Hospital

Hospital pneumonia oxygen therapy is the staged use of supplemental oxygen and respiratory support to correct hypoxemia while treating the underlying infection. In practice, clinicians move from low-flow nasal oxygen to controlled-flow devices, high-flow nasal cannula, noninvasive ventilation, invasive mechanical ventilation, and, in exceptional cases, extracorporeal membrane oxygenation (ECMO). The appropriate level is guided by oxygen saturation, work of breathing, blood-gas results, mental status, hemodynamics, and response to treatment—not by pneumonia diagnosis alone. This matters because lower respiratory infections remain a major global cause of death: the World Health Organization reported that lower respiratory infections caused approximately 2.5 million deaths worldwide in 2019, including 672,000 children under five.

Oxygen-Therapy Levels for Hospital Pneumonia

The entity-attribute pairing in this topic is “hospital pneumonia oxygen-therapy level”: the entity is respiratory support used for a patient with pneumonia, and the attribute is the intensity or delivery method required to maintain adequate oxygenation. The American Thoracic Society and Infectious Diseases Society of America define severe community-acquired pneumonia through clinical criteria such as respiratory failure requiring mechanical ventilation, while the British Thoracic Society and World Health Organization emphasize assessing oxygenation, respiratory distress, and clinical deterioration when selecting support.

The principal hyponyms are conventional oxygen therapy, high-flow nasal cannula, noninvasive ventilation, invasive mechanical ventilation, and rescue therapies such as prone positioning or ECMO. These levels are not rigid steps that every patient must follow. A person with profound hypoxemia may require immediate advanced support, whereas another patient may improve with a low-flow nasal cannula and antibiotics.

Oxygen targets and assessment

Oxygen therapy is indicated when pneumonia causes hypoxemia or increased respiratory effort. Pulse oximetry provides a rapid estimate of peripheral oxygen saturation, while an arterial or venous blood gas can add information about carbon dioxide, acidity, and respiratory failure. For many acutely ill adults, clinicians commonly target a saturation of about 92–96%. The British Thoracic Society recommends a lower target of 88–92% for patients at risk of hypercapnic respiratory failure, including some people with severe chronic obstructive pulmonary disease, because excessive oxygen can worsen carbon-dioxide retention.

Targets must be individualized. A falling saturation, rising respiratory rate, inability to speak in full sentences, exhaustion, confusion, cyanosis, shock, or worsening blood-gas results can signal that the current level is inadequate. Oxygen saturation alone is therefore insufficient: a patient can maintain a borderline saturation while developing dangerous fatigue or impaired ventilation.

Low-flow nasal cannula

A nasal cannula is the usual first-line device for mild to moderate hypoxemia. It delivers oxygen through two small nasal prongs, typically at approximately 1–6 liters per minute, although exact performance depends on breathing pattern and mouth breathing. The delivered fraction of inspired oxygen is variable and often approximated at about 24–44%.

Its advantages are comfort, ease of eating and speaking, and suitability for ward-based care. Limitations include unreliable oxygen delivery during rapid or deep breathing and irritation or dryness of the nose. If oxygen requirements continue to rise or respiratory distress persists, a simple mask or a more advanced device may be appropriate.

Simple face mask and Venturi mask

A simple face mask generally supplies roughly 5–10 liters per minute and may provide an inspired oxygen concentration of approximately 35–60%. Flow should not usually be set below 5 liters per minute because inadequate flow can permit rebreathing of exhaled carbon dioxide. It is useful when nasal oxygen is insufficient or poorly tolerated, but it can interfere with eating, communication, and secretion clearance.

A Venturi mask is a controlled-oxygen device that uses interchangeable adapters to deliver a more predictable oxygen concentration, commonly around 24–60%. This precision is valuable for patients who require careful oxygen titration, particularly those vulnerable to hypercapnic respiratory failure. Device performance still depends on using the correct adapter and prescribed flow.

Non-rebreather mask

A non-rebreather mask is a high-concentration conventional oxygen device with a reservoir bag and one-way valves. At flows commonly set around 10–15 liters per minute, it can deliver a high inspired oxygen concentration, often approaching 60–90% when fitted correctly and when the reservoir remains inflated.

This device is often used temporarily for severe hypoxemia while clinicians evaluate the patient and prepare high-flow therapy or intubation if needed. It is not a substitute for definitive ventilatory support in a patient who is tiring, retaining carbon dioxide, unable to protect the airway, or developing circulatory instability.

Advanced Respiratory Support in Pneumonia

When conventional oxygen does not achieve the clinical target, the next level is determined by whether the main problem is oxygenation, ventilation, work of breathing, or airway protection. This distinction connects oxygen-delivery devices with positive-pressure therapies, which support breathing mechanics rather than simply increasing the oxygen concentration.

High-flow nasal cannula

High-flow nasal cannula (HFNC) delivers heated, humidified gas through wide-bore nasal prongs at flows that can reach approximately 60 liters per minute in adults, with an adjustable oxygen concentration up to 100%. The high flow can reduce dilution by room air, decrease anatomical dead space, improve humidification, and create a small amount of positive airway pressure.

HFNC is commonly considered when conventional oxygen requires high flow or when the patient has persistent respiratory distress. The FLORALI randomized trial, published in the New England Journal of Medicine in 2015, found that HFNC improved some outcomes in acute hypoxemic respiratory failure, particularly among patients with more severe hypoxemia, although later studies have shown that results depend on patient selection and timing.

Clinical teams should reassess HFNC early rather than allowing delayed escalation. The ROX index—oxygen saturation divided by the fraction of inspired oxygen, then divided by respiratory rate—has been studied as a supplemental predictor of HFNC success, but it does not replace bedside assessment. Worsening distress, deteriorating gas exchange, hemodynamic instability, or reduced alertness may require intubation.

Noninvasive ventilation: CPAP and BiPAP

Noninvasive ventilation uses a tight-fitting mask to provide positive pressure without an endotracheal tube. Continuous positive airway pressure (CPAP) supplies one continuous pressure and can improve alveolar recruitment and oxygenation. Bilevel positive airway pressure (BiPAP) provides higher pressure during inspiration and lower pressure during expiration, which can assist ventilation and reduce the work of breathing.

Noninvasive ventilation is particularly established for acute exacerbations of chronic obstructive pulmonary disease with respiratory acidosis and for cardiogenic pulmonary edema. In pneumonia-related hypoxemic respiratory failure, it may be considered in carefully selected, cooperative patients who can protect their airway and who are closely monitored. Pneumonia can cause rapid deterioration, and an unsuccessful trial may dangerously delay intubation.

Invasive mechanical ventilation

Invasive mechanical ventilation uses an endotracheal tube connected to a ventilator. It is indicated when pneumonia produces refractory hypoxemia, severe respiratory acidosis, exhaustion, inability to protect the airway, recurrent aspiration, respiratory arrest, or shock requiring airway control. Intubation also permits more reliable control of oxygen concentration, respiratory rate, tidal volume, and airway pressure.

For pneumonia-associated acute respiratory distress syndrome (ARDS), lung-protective ventilation is central. The ARDSNet trial established the benefit of using a lower tidal volume of approximately 6 milliliters per kilogram of predicted body weight rather than 12 milliliters per kilogram, reducing mortality from 39.8% to 31.0% in the study population. Clinicians also limit plateau pressure, commonly to less than 30 centimeters of water, to reduce ventilator-induced lung injury.

Prone positioning and ECMO

Prone positioning places a mechanically ventilated patient on the abdomen to improve ventilation-perfusion matching and recruit dependent lung regions. The PROSEVA trial found that prolonged prone positioning—at least 16 hours per day—in patients with severe ARDS reduced 28-day mortality from 32.8% to 16.0% when combined with lung-protective ventilation.

ECMO is a specialized rescue therapy that circulates blood through an artificial lung when severe respiratory failure persists despite optimized ventilation and other measures. Venovenous ECMO may be considered for potentially reversible, life-threatening hypoxemia at an experienced center. It requires anticoagulation, specialized staffing, and careful selection because complications include bleeding, thrombosis, infection, and neurologic injury.

Clinical Escalation, Monitoring, and Safety

A practical escalation pathway

A typical hospital pathway begins with pulse-oximetry assessment, positioning, secretion management, antimicrobial treatment, and low-flow oxygen when indicated. If the target cannot be maintained, the team may progress to a Venturi mask, non-rebreather mask, or HFNC. CPAP or BiPAP may be selected for an appropriate patient, while immediate invasive ventilation is preferred when there is airway compromise, severe fatigue, or rapidly worsening gas exchange.

• Recheck oxygen saturation, respiratory rate, work of breathing, mental status, and blood pressure after each intervention.
• Confirm that the device is fitted correctly and that tubing, oxygen supply, humidification, and reservoir function are adequate.
• Investigate a sudden increase in oxygen requirement for complications such as pneumothorax, mucus plugging, pulmonary embolism, fluid overload, or worsening ARDS.
• Escalate promptly when support is failing; prolonged high oxygen requirements can obscure clinical deterioration.
• Use infection-control precautions, especially when aerosol-generating procedures such as noninvasive ventilation or intubation are performed.

Oxygen is supportive, not curative

Supplemental oxygen corrects hypoxemia but does not eradicate bacterial, viral, or fungal pneumonia. Treatment may also require antibiotics, antiviral therapy when indicated, fluids or vasopressors for shock, bronchodilators for coexisting bronchospasm, thromboprophylaxis, nutrition, physiotherapy, and management of comorbid disease. The need for oxygen should decline as the infection and inflammatory lung injury resolve, although severe pneumonia or ARDS can require prolonged rehabilitation.

The World Health Organization, national respiratory societies, and hospital protocols generally support titrating oxygen to a defined target rather than giving the highest possible concentration indefinitely. Excessive oxygen exposure can contribute to absorption atelectasis, oxidative injury, and other complications, while insufficient oxygen can damage organs. The safest approach is therefore frequent reassessment and the lowest effective level of support.

Conclusion: Matching Pneumonia Severity to Oxygen Support

Hospital pneumonia oxygen-therapy levels range from low-flow nasal cannula and controlled-flow masks to non-rebreather masks, HFNC, CPAP or BiPAP, invasive mechanical ventilation, prone positioning, and ECMO. Oxygen targets commonly fall near 92–96% for many acutely ill adults, with 88–92% often used for patients at risk of hypercapnic respiratory failure. The choice depends on oxygenation, ventilation, work of breathing, consciousness, circulation, comorbidities, and the speed of deterioration.

The broader implication is that oxygen delivery must be treated as a dynamic clinical process rather than a single prescription. Early recognition of worsening respiratory failure, evidence-based lung-protective ventilation, and timely escalation can improve safety. Patients, families, and non-specialist clinicians should seek urgent medical evaluation for increasing breathlessness, confusion, blue or gray lips, chest pain, inability to speak normally, or a rapidly falling oxygen saturation. Further reading should focus on current local hospital protocols, the British Thoracic Society oxygen guideline, the ATS/IDSA community-acquired pneumonia guideline, and ARDS ventilation guidance.

Sources: World Health Organization, Pneumonia, https://www.who.int/news-room/fact-sheets/detail/pneumonia; British Thoracic Society, BTS Guideline for Oxygen Use in Adults in Healthcare and Emergency Settings, https://www.brit-thoracic.org.uk/quality-improvement/guidelines/emergency-oxygen/; Metlay JP et al., Diagnosis and Treatment of Adults with Community-acquired Pneumonia: An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America, https://doi.org/10.1164/rccm.201908-1581ST; Frat JP et al., High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure, New England Journal of Medicine, https://doi.org/10.1056/NEJMoa1503326; Brower RG et al., Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome, New England Journal of Medicine, https://doi.org/10.1056/NEJMoa012250; Guérin C et al., Prone Positioning in Severe Acute Respiratory Distress Syndrome, New England Journal of Medicine, https://doi.org/10.1056/NEJMoa1214103; Fan E et al., An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with ARDS, https://doi.org/10.1164/rccm.201703-0548ST.